Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 5Rectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Neoplasms 4Head and Neck Neoplasms 4Glioblastoma 4Colorectal Neoplasms 4Stomach Neoplasms 3Glioma 3Esophageal Neoplasms 3Breast Neoplasms 3Brain Neoplasms 3Astrocytoma 3Recurrence 2Pancreatic Neoplasms 2Osteosarcoma 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2Lung Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma, Hepatocellular 2Wilms Tumor 1Skin Neoplasms 1Sinonasal Squamous Cell Carcinoma 1Sarcoma 1Rhabdomyosarcoma 1Radiation Injuries 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Postoperative Complications 1

Interventions

Cyclophosphamide 25fludarabine 19Dexamethasone 17pembrolizumab 13Rituximab 12venetoclax 9Lenalidomide 9Gemcitabine 9Etoposide 9pomalidomide 8Vincristine 7glofitamab 6fludarabine phosphate 6carfilzomib 6Temozolomide 6obinutuzumab 5daratumumab 5Prednisone 5Nivolumab 5Doxorubicin 5Cisplatin 5Calcium Dobesilate 5Bortezomib 5zanubrutinib 4selinexor 4Immunotherapy, Adoptive 4Cytarabine 4Carboplatin 4Azacitidine 4ruxolitinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recurrence × Surgical Procedures, Operative × 90 days × Clear all
NCT07470294 2026-03-13

PiloPedia

University Hospital, Angers

Not yet recruiting
90 enrolled

Pilonidal Sinus, Recurrence

NCT06868433 2026-03-04

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Emory University

Phase 1 Recruiting
40 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡